iShares U.S. Pharmaceuticals ETF (IHE) Dividend Yield, History & Forecast

iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 1.43% ($1.47 per share annually (TTM)). The most recent ex-dividend date was June 15, 2026, with payment scheduled for June 18, 2026. market capitalization is approximately $1.13B.

IHE fund composition

IHE holds 56 positions, with 75.1% of assets in its ten largest. It charges an expense ratio of 0.37%, and manages $1.64B.

Top 10 holdings

HoldingWeight
JNJJOHNSON & JOHNSON22.06%
LLYELI LILLY20.26%
BMYBRISTOL MYERS SQUIBB4.89%
VTRSVIATRIS4.61%
MRKMERCK & CO INC4.44%
RPRXROYALTY PHARMA PLC CLASS A4.35%
PFEPFIZER4.10%
ZTSZOETIS INC CLASS A3.86%
JAZZJAZZ PHARMACEUTICALS PLC3.67%
ELANELANCO ANIMAL HEALTH2.86%

Sector allocation

Healthcare100.0%

Frequently Asked Questions about iShares U.S. Pharmaceuticals ETF (IHE)

What is iShares U.S. Pharmaceuticals ETF's dividend yield?
iShares U.S. Pharmaceuticals ETF (IHE) pays a current trailing twelve-month dividend yield of 1.43%, which works out to $1.47 per share annually based on the most recent payout schedule.
When does iShares U.S. Pharmaceuticals ETF pay distributions?
The most recent ex-dividend date was June 15, 2026. The next scheduled dividend payment date is June 18, 2026.
How many years has iShares U.S. Pharmaceuticals ETF increased its dividend?
iShares U.S. Pharmaceuticals ETF (IHE) has increased its dividend for 2 consecutive years.
What does iShares U.S. Pharmaceuticals ETF invest in?
The iShares U.S. Pharmaceuticals ETF is designed to replicate the investment performance of a benchmark index. This index consists solely of equity securities from pharmaceutical companies operating within the United States.